Novo Nordisk A/S ROA Ratio 2011-2026 | NVO

Annual ROA Ratio Novo Nordisk A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	24.55	29.08	31.01	34.87	37.25	38.88	37.97	34.36	35.8	32.64	26.43

All numbers in DKK currency

Indicator range from annual reports

Maximum	Minimum	Average
38.88	24.55	32.99

ROA Ratio of other stocks in the Biotechnology industry

Issuer	ROA Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	-232.99	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-72.8	-	-	$ 86.2 M	USA
MorphoSys AG MOR	-20.13	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	-31.06	$ 3.85	3.22 %	$ 9.26 B	Australia
Akouos AKUS	-31.09	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	6.32	$ 326.56	-2.05 %	$ 42.8 B	USA
Applied Molecular Transport AMTI	-117.57	-	-	$ 10.1 M	USA
I-Mab IMAB	7.43	-	-	$ 866 M	China
AlloVir ALVR	-35.68	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	3.33	-	-	$ 40.3 B	USA
Genfit SA GNFT	23.87	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-89.6	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	-27.33	$ 7.76	4.51 %	$ 76.7 M	USA
Allakos ALLK	-76.23	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	-489.29	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	-53.39	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-42.28	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	-218.41	-	-	$ 8.42 M	USA
Aptinyx APTX	-97.25	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-122.8	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	-1008.51	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	6.02	$ 21.48	-0.92 %	$ 1 B	USA
Burford Capital Limited BUR	5.51	$ 4.7	-0.74 %	$ 756 M	Britain
CymaBay Therapeutics CBAY	-24.24	-	-	$ 3.45 B	USA
Cabaletta Bio CABA	-101.68	$ 3.45	1.32 %	$ 347 M	USA
BioNTech SE BNTX	65.02	$ 99.42	-0.05 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	4.82	-	-	-	Russia
Advaxis ADXS	-289.96	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-10.45	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	-103.3	$ 3.1	-4.32 %	$ 5.1 M	Israel
AgeX Therapeutics AGE	-275.96	-	-10.17 %	$ 12.2 K	USA
ContraFect Corporation CFRX	-315.07	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	-19.95	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	-1.42	$ 1.41	-9.12 %	$ 363 M	USA
Applied Genetic Technologies Corporation AGTC	-27.57	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	-52.23	$ 4.16	-1.89 %	$ 445 M	USA
Arcutis Biotherapeutics ARQT	-3.73	$ 24.22	-1.46 %	$ 3.08 B	USA
AIkido Pharma AIKI	-19.87	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	26.14	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	-48.81	$ 1.48	-0.67 %	$ 394 M	Britain
Aptose Biosciences APTO	-254.37	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	3.5	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	-752.78	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	-57.1	-	-16.75 %	$ 25.8 M	USA
AVROBIO AVRO	12.03	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	-95.49	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	-44.38	$ 33.53	-1.0 %	$ 2.23 B	USA
bluebird bio BLUE	-34.23	-	-	$ 546 M	USA
CNS Pharmaceuticals CNSP	-183.81	$ 2.66	-3.34 %	$ 1.18 M	USA
AstraZeneca PLC AZN	0.11	-	-	$ 96.9 B	Britain